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Plasmacytoid Dendritic Cells Induce
Plasma Cell Differentiation
through Type I Interferon and Interleukin 6
enter into apoptosis unless provided with an appropriate
signal. Perhaps the most significant feature of pDCs is
their capacity to promptly produce considerable amounts
of type I IFN upon exposure to viruses as well as bacte-
rial components such as CpG oligonucleotides (Asselin-
Gaetan Jego, A. Karolina Palucka,
Jean-Philippe Blanck, Cecile Chalouni,
Virginia Pascual,1 and Jacques Banchereau1,*
Baylor Institute for Immunology Research
3434 Live Oak Street
Dallas, Texas 75204 Paturel et al., 2001; Bjorck, 2001; Cella et al., 1999; Kado-
waki et al., 2000; Nakano et al., 2001; Siegal et al., 1999).
The release of IFN- initiates a cascade of events that
leads to the elimination of the virus. In particular, IFN-
Summary
acts directly on most cell types to turn on biochemical
pathways that restrict viral replication and render host
Dendritic cells (DCs) initiate and control immune re-
cells resistant to further viral infection (Katze et al., 2002).
sponses. Plasmacytoid DCs (pDCs) represent a unique
IFN also activates NK cells, which can lyse virally in-
DC subset able to promptly release large amounts of
fected cells (Biron et al., 1999). Finally, virally triggered
type I interferon (IFN-) upon viral encounter. Here
pDCs differentiate into mature DCs able to induce the
we report that depletion of pDCs from human blood
differentiation of CD4 T cells into IFN-- and IL-10-
mononuclear cells abrogates the secretion of specific
secreting cells (Kadowaki et al., 2000). These cytokines
and polyclonal IgGs in response to influenza virus.
further contribute to antiviral protection directly and indi-
Furthermore, purified pDCs triggered with virus induce
rectly by recruiting other immune effectors. Thus, IFN-
CD40-activated B cells to differentiate into plasma
is an antiviral agent as well as an activator of CTLs
cells. Two pDC cytokines act sequentially, with IFN-
(Boehm et al., 1997). Furthermore, IL-10 (Moore et al.,
generating non-Ig-secreting plasma blasts and IL-6
2001) is a known activator of CTL precursors (MacNeil
inducing their differentiation into Ig-secreting plasma
et al., 1990) and a potent stimulator of plasma cell differ-
cells. These plasma cells display the high levels of
entiation (Fluckiger et al., 1993; Rousset et al., 1992).
CD38 found on tissue plasma cells. Thus, pDCs are
Activated T cells differentiate into (1) CTLs that eliminate
critical for the generation of plasma cells and antibody
virally infected cells and (2) memory T cells. Plasma cells
responses.
produce neutralizing antibodies and, when long-lived,
may provide the most efficient and life-long protection
against viral infection (Manz et al., 1998, 2002; SlifkaIntroduction
and Ahmed, 1996).
While the majority of the studies on DCs have focusedThe immune system evolved to protect us from microbes
by the coordinated actions of innate and adaptive immu- on their ability to trigger T cell responses, early studies
clearly indicated that they may act on other immunenity (Janeway and Medzhitov, 2002; Medzhitov and
Janeway, 1998). In response to viral encounter, the cells effectors including B cells (Dubois et al., 1997; Fayette
et al., 1997; Garcia De Vinuesa et al., 1999; Sornasse etof innate immunity, including epithelial cells, NK cells,
and plasmacytoid dendritic cells (pDCs), secrete inter- al., 1992). Indeed, myeloid DCs have been shown to
trigger B cell growth and differentiation through the re-ferons, a family of cytokines with potent antiviral proper-
ties (Biron et al., 1999; Katze et al., 2002). Adaptive lease of soluble factors such as IL-12 and IL-6 (Dubois
et al., 1998) and/or membrane molecules such as BAFF/immunity provides T cells that secrete interferon  and
differentiate into cytotoxic T cells (Guidotti and Chisari, APRIL (Balazs et al., 2002; Litinskiy et al., 2002; MacLen-
nan and Vinuesa, 2002). Little is known, however, about2001) and B cells that generate antibody-secreting
plasma cells (Bachmann and Zinkernagel, 1997). Den- the role of pDCs in B cell differentiation. We now show
that virus-triggered pDCs induce, through IFN- anddritic cells (DCs), in addition to their role in innate immu-
nity, induce and regulate adaptive immune responses IL-6 release, the generation of plasma cells secreting
virus-specific antibodies.(Banchereau et al., 2000; Banchereau and Steinman,
1998; Shortman and Liu, 2002; Steinman, 1991).
Distinct DC subsets exist that are endowed with differ- Results
ent properties and lead to different types of immune
responses. In the human, two major DC pathways have pDCs Are Essential for Ig Production by Blood
been identified, the myeloid DCs (O’Doherty et al., 1994) Mononuclear Cells
that include interstitial DCs and Langherhans cells, and Human blood mononuclear cells can be induced to se-
plasmacytoid DCs (pDCs) (Grouard et al., 1997). pDCs crete Igs in vitro in response to a wide variety of agents
display dramatically different physiology as compared including polyclonal stimulators (for example, PWM,
to other DC subsets. For example, pDCs isolated from SAC, PHA) as well as viruses (for example, influenza
blood are small cells that morphologically resemble virus) (Banchereau and Rousset, 1992). Given the role
plasma cells with rich endoplasmic reticulum and readily of pDCs in controlling virus spread through the produc-
tion of large amounts of type I IFN, we wondered whether
they would also be involved in the generation of virus-*Correspondence: jacquesb@baylorhealth.edu
1These authors contributed equally to this work. specific antibodies. To this end, we exposed peripheral
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Figure 1. pDC Depletion from PBMC Abrogates Influenza-Specific Antibody Production
(A) Phenotypic characterization of PBMCs before (lower left) and after (lower right) depletion of BDCA4-positive cells. pDCs (CD11cneg CD123pos)
are analyzed within viable cells (R1) and Linneg HLA-DRhigh cells (R2) (one of five experiments).
(B) Decreased IFN- secretion upon influenza virus stimulation by 1  106 PBMCs before (black bars) and after (white bars) pDC depletion.
(C) Anti-flu IgG levels in supernatants of 1  106 PBMCs or PBMCs depleted of pDCs and cultured for 15 days with influenza virus and IL-2
(one of four experiments).
(D) Total IgG concentration in PBMCs or PBMC-pDCs cultured with influenza virus and IL-2 (one of five experiments).
(E) Percentage of CD4-, CD8-, CD19-, CD56-, and CD14-positive cells in PBMCs before (black bars) or after pDC depletion (white bars) (one
of two experiments).
(F) Numbers of PBMCs after 15 days of culture (two of three experiments). The insert shows the number of CD19 cells in these two experiments.
blood mononuclear cells (PBMCs) as well as PBMCs sulted in 90% inhibition of IFN- secretion after 48 hr
exposure to live influenza virus (Figure 1B). PBMCs anddepleted of pDCs to live influenza virus in vitro. pDCs
were depleted with BDCA4-coupled magnetic beads pDC-depleted PBMCs were cultured with live influenza
virus for 2 weeks. Supernatants were then tested by(Dzionek et al., 2000), which removed 95% of pDCs
identified as CD123 CD11c HLA-DR cells lacking ELISA for both influenza-specific antibodies and total
immunoglobulins. As shown in Figure 1C, depletion oflineage markers (0.3% pDCs before and 0.01% pDCs
after depletion, Figure 1A). The depletion of pDCs re- pDCs at culture onset completely abrogated secretion of
pDCs Control Plasma Cells with IFN- and IL-6
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Figure 2. pDCs Enhance the Production of Influenza-Specific Antibodies by Purified B Cells Cocultured with T Cells and Virus
(A) Concentration of IgG against influenza virus, adenovirus, measles virus, in the 15 day coculture of 2  105 autologous B and T cells,
influenza virus, and IL-2, with (black bars) or without (white bars) 5  103 pDCs (one of two experiments).
(B) Anti-flu IgG concentration in duplicates of four independent experiments (paired t test).
(C) Total IgG and IgM in experiment illustrated in (A) in the presence of influenza virus (one of two experiments).
(D) Total IgG from duplicates of two independent experiments in the same conditions as (A) in the presence of influenza virus (paired t test).
influenza-specific antibodies. This inhibition of specific using BDCA-4 beads. BDCA-4-positive blood pDCs
were also able to induce B cell differentiation (data notantibody secretion reflected the inhibition of total immu-
noglobulin secretion, as no IgG could be detected in shown).
Supernatants of cocultures with influenza virus werethe supernatants of pDC-depleted PBMCs (Figure 1D).
The lack of Ig secretion was not due to the death of harvested at day 15 for determination of total immuno-
globulins and virus-specific antibodies. In the absencePBMCs. Indeed, pDC depletion did not alter the fre-
quency of various cell populations at the onset of culture of pDCs, B cells cocultured with influenza virus, T cells,
and IL-2 produce low levels of influenza-specific IgG(Figure 1E). Upon culturing, B cells were present in the
end of the culture albeit at reduced numbers (50%, (Figure 2A) with a mean level of 255 A.U./ml (Figure 2B).
However, addition of only 5000 pDCs to the coculturesFigure 1F).
Thus, pDCs are essential for the production of influ- results in a 7-fold enhancement of Flu-specific IgG se-
cretion (Figure 2A) with a mean level of 1782 A.U./mlenza virus-specific IgG by blood mononuclear cells.
(Figure 2B, p  0.01). Figure 2B shows the replicates of
four independent experiments carried out with cells fromPurified CD40-Activated Human B Cells Secrete Igs
When Exposed to pDCs and Virus four different donors. The secretion of Flu-specific anti-
bodies is accompanied by polyclonal activation of IgGWe next analyzed whether pDCs directly interact with
B cells. Human B cells, purified by positive selection secretion (Figures 2C and 2D, 3.4-fold increase, p 
0.003). Yet, neither anti-measles nor anti-adenovirus an-using CD19-beads, were exposed to three signals: influ-
enza virus (the antigen), pDCs (the antigen-presenting tibodies could be detected in cocultures with influenza
virus (Figure 2A). Figure 2D shows the results of thecell), and T cells. Through most of this study, pDCs were
sorted from cultures of CD34 hematopoietic progeni- replicates of two independent experiments carried out
with cells from two different donors. The Ig secretiontors made in the presence of FLT-3L and TPO (Blom et
al., 2000). In some cases, however, to ensure that cul- appears to be mostly IgG, as little IgM could be detected
(Figure 2C, right panel).tured pDCs behave as those isolated from blood, experi-
ments were carried out with pDCs isolated from blood To further understand the mechanisms through which
Immunity
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Figure 3. pDCs Enhance IgG Production by
CD40-Activated B Cells
104 B cells were cultured over CD40L L cells
with IL-2 in the absence or presence of pDCs.
(A) Total IgG secretion in the absence or pres-
ence of 5  103 pDCs from duplicates of six
independent experiments (paired t test).
(B) Low numbers of pDCs enhance IgG secre-
tion. Increasing numbers of pDCs were cul-
tured with B cells during day 15 (one of four
experiments).
(C) pDC stimulation of IgG secretion is depen-
dent on the presence of the virus. B cells were
cultured with or without influenza virus in the
absence (white bars) or presence of 5  103
pDCs (black bars) (one of two experiments).
pDCs enhance antibody secretion, we replaced the release of three soluble factors: IL-12, IL-6, and gp80,
T cells by CD40L transfected L cells. As shown in Figure a component of the IL-6 receptor (Dubois et al., 1998).
3A, the addition of 5000 pDCs to CD40-activated B cells We thus wondered whether pDCs induced B cell differ-
cultured with Flu virus resulted in a 10-fold increase of entiation was also mediated by soluble factor(s). To this
IgG production (12 replicates of six independent experi- end, cultures were performed in Transwells where B
ments, p  0.0001). As few as 1000 pDCs suffice for cells are separated from pDCs by a semipermeable
significant enhancement of IgG secretion (Figure 3B). membrane. There, B cells are still able to secrete large
However, in the absence of virus (Figure 3C, left panel), amounts of IgG (Figure 4C). The differentiation required
pDCs do not enhance antibody production, suggesting both the virus and CD40 signaling. Consequently, the
a critical role for the virus in the secretion of IgG. supernatant of pDCs exposed to virus and activated
Thus, pDCs can induce activated B cells to secrete Igs. through CD40 is able to induce CD40-activated B cells to
differentiate into CD20lo CD38hi plasma cells (Figure 4D).
pDCs Induce CD40-Activated B Cells to Differentiate This prompted us to identify the pDC factor(s) involved
into Plasma Cells in plasma cell differentiation and IgG secretion. pDCs
Antibodies are produced by plasma cells, the end stage have been shown to secrete a limited set of cytokines
of B cell differentiation. Hence, pDC-dependent secre- among which IFN- (Morikawa et al., 1987) and IL-6
tion of Flu-specific antibodies suggested the role of pDC are known to signal B cells (Kumanogoh et al., 1997).
in driving plasma cell differentiation. While CD40-acti- In Figure 5A, the addition of pDCs to CD40-activated B
vated B cells are CD20hi CD38lo (Figure 4A, 1), a signifi- cells increases IgG secretion 11-fold (from 0.18 	g/ml
cant fraction of these cells (43%) become CD20lo CD38hi to 1.98 	g/ml; one experiment representative of five
plasma cells when cultured with IL-2IL-10 (Arpin et al., showing a mean 12.7 
 9.7-fold increase; range 3–26).
1995) (Figure 4A, 2). Likewise, CD40-activated B cells The secretion of IgG could be prevented by the addition
exposed to pDCs and virus acquire a plasma cell pheno- of neutralizing antibodies to (1) IFN- alone (p  0.05),
type (43%, Figure 4A, 3). The expression of CD38 on
(2) IFN- and IFN- together with anti-IFN- receptor
the CD20lo cells in these cultures is higher than that
antibody (p  0.0005), or (3) IL-6 (p  0.0005) (Figuresobserved in IL-10-driven cultures. Such CD38 expres-
5A and 5B). Ig secretion results from a two-step differen-sion intensity is comparable to that of plasma cells iso-
tiation process whereby activated B cells first differenti-lated from either blood (Figure 4A, 4) or tonsils (data not
ate into proliferating non-Ig-secreting plasma blasts thatshown). Confocal microscopy using Texas red-labeled
subsequently yield Ig-secreting plasma cells (Jego etanti-HLA-DR and FITC-labeled anti-IgG further confirms
al., 1999). As shown in Figure 5C, adding antibodiesthe generation of plasma cells with a typical morphology
blocking IFN- (against both cytokines and receptor)and intense intracytoplasmic Ig staining (Figure 4B).
resulted in60% inhibition of CD20lo CD38hi plasma cellThus, pDCs drive the differentiation of CD40-activated
differentiation while neutralization of IL-6 gave 25%B cells into plasma cells.
inhibition. To further understand the role of each cyto-
kine, CD40-activated B cells were cultured with eitherpDCs Induce Plasma Cell Differentiation
IFN-, IFN-, or IL-6, and the cell phenotype was deter-through Type I Interferon and IL-6
mined 7 days later. As shown in Figure 5D, adding IFN-We demonstrated earlier that CD40-activated mDCs in-
duce the differentiation of activated B cells through the or IFN-, but not IL-6, induced activated B cells to ac-
pDCs Control Plasma Cells with IFN- and IL-6
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Figure 4. pDCs Induce CD40-Activated B Cells to Become Plasma Cells in a Contact-Independent Fashion
(A) Activated B cells acquire a plasma cell phenotype in coculture with pDCs and virus. Phenotype of activated B cells after 7 days of culture
in medium alone, IL-2, and IL-10, or with 2  104 virus-activated pDCs; the boxed number is the frequency of CD20lo CD38hi plasma cells (one
of five experiments with pDCs). Far right is the CD38 expression of CD19 peripheral blood cells (one of three experiments).
(B) After 8 days of coculture, plasma cells are detected by bright anti-Ig staining (green) and pDCs by bright anti-HLA-DR staining (red).
Confocal microscopy, 63 magnification.
(C) The secretion of IgG is dependent on the production of soluble factor(s) by pDCs after CD40 engagement. IgG production by B cells over
CD32 L cells (white bars) and over CD40L L cells (black bars) was measured in the upper well of the Transwells plate (one of two experiments).
Each bar represents one well.
(D) Phenotypic differentiation of activated B cells into plasma cells is contact independent. Frequency of CD20lo CD38hi plasma cells generated
in culture of 105 activated B cells with medium or virus-activated-pDC-supernatant after 7 days (one of three experiments).
quire a plasma cell phenotype. However, neither IFN- IFN- induces differentiation of activated B cells into
nonsecreting plasma blasts, which in response to IL-6nor IL-6 together with IL-2 was able to trigger Ig’s secre-
tion (Figure 5E), and only their combination resulted in become Ig-secreting plasma cells.
the secretion of IgG, demonstrating cooperation be-
tween both cytokines (Figure 5E). Yet, Ig secretion ob- Discussion
tained with IFN- and IL-6 is lower than this obtained
with pDCs, suggesting that other factors/cytokines pro- In this study, we demonstrate a novel biological function
of pDCs, their critical role in the generation of antibodyduced by pDCs are involved, the nature of which is
currently unknown. In those conditions, the Ig secretion responses. We show that depletion of pDCs from blood
mononuclear cells abrogates secretion of immunoglob-was independent of the addition of the virus (data not
shown). Interestingly, while virus alone was able to acti- ulins including influenza-specific ones and that pDCs
control the differentiation of activated B cells intovate pDCs to secrete IFN-, the levels of IL-6 were mod-
est, thus explaining why B cells do not differentiate into plasma cells through the secretion of IFN- and IL-6.
On the basis of our results we propose a model forIg-secreting cells when pDCs are triggered with virus in
the absence of CD40 signaling (see column 4 of Figure development of virus-specific humoral immune re-
sponses (Figure 6). Accordingly, upon virus encounter4C). Indeed, pDCs required CD40 signaling for secretion
of high levels of IL-6 (fold increase 31.1 
 33, mean 
 pDCs promptly secrete IFN- and differentiate into ma-
ture DCs presenting viral antigens to T cells (FonteneauSD, range 5.6–93 [n  6]) (Figure 5F).
Thus, pDCs induce the differentiation of activated B et al., 2003). T cells secrete IL-2 and express CD40L,
which signals pDCs to secrete IL-6 and also activatescells into Ig-secreting plasma cells through release of
IFN- and IL-6 that act in sequential fashion. First, B cells. pDC-derived IFN- induces B cells to differenti-
Immunity
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Figure 5. pDC-Induced Plasma Cell Differentiation Is Dependent on IFN- and IL-6
(A) Neutralization of IFN- and IL-6 abolishes the pDC-induced IgG secretion by B cells. Levels of IgG secreted by CD40-activated B cells
in the presence of IL-2 and 5  103 virus-activated pDCs with or without anti-IFN-, anti-IFN-, anti-IFN-R, and anti-IL-6/6R-blocking Abs
(one of five experiments).
(B) Percentage of inhibition of IgG secretion of five experiments in the same condition as in (A). Control Ab, ; anti-IFN-, ; anti-IFN-, ;
anti-IFN-, ; anti-IL-6/6R, . *p  0.05, ***p  0.0005.
(C) Neutralization of IFN- strongly inhibits the pDC-induced differentiation of CD38hi CD20lo B cells toward plasma cells. Frequency of
plasma cells at day 7 of culture of activated B cells with medium, virus-activated-pDCs with or without anti-IFN-R, or/and anti-IL-6/6R-
blocking Abs (one of two experiments).
(D) IFN- induces the phenotypic differentiation of activated B cells into plasma cells. 105 activated B cells were cultured with medium,
IFN-, IFN-, or IL-6 during 7 days before staining for CD20lo CD38hi plasma cells (one of four experiments).
(E) IgG production in cultures of CD40-activated B cells supplemented with IL-2 and either IFN-, IL-6, or both (one of three experiments).
(F) IL-6, but not IFN-, secretion is strongly increased after dual CD40 and virus stimulation of 4  104 pDCs during 48 hr (one of three
experiments).
ate into plasma blasts while pDC-derived IL-6 permits BLyS and APRIL, support this hypothesis (Balazs et al.,
2002; Litinskiy et al., 2002; MacLennan and Vinuesa,plasma blasts to become antibody-secreting plasma
cells. 2002).
The importance of DCs in the establishment of hu-We surmise that T cells are a necessary component
in the B cell/pDC interaction for the generation and se- moral responses has been recognized for some time.
However, it was demonstrated only for myeloid DCscretion of virus-specific antibodies because (1) CD40
ligand plays a critical role in the activation of B cells and considered to be mediated by T cells that, once
activated by DCs, would in turn activate B cells (Inabaand in the enhancement of IL-6 secretion by pDCs, and
(2) plasma cell differentiation is also supported by T cell- et al., 1983; Sornasse et al., 1992). These studies, how-
ever, did not consider the possibility that DCs interactderived IL-2 and IL-10. However, CD40 ligand could be
provided by cells other than activated T cells, including directly with B cells and present them with unprocessed
antigen (Wykes et al., 1998). We have previously demon-activated endothelial cells (Mach et al., 1997), mast cells
(Gauchat et al., 1993), platelets (Henn et al., 1998) as strated that myeloid DCs, generated by culturing CD34
hematopoietic stem cells, are able to enhance B cellwell as activated B cells themselves (Grammer et al.,
1995). Under these circumstances, a T cell-independent proliferation and isotype switching toward IgA (Fayette
et al., 1997), as well as plasma cell differentiation (Fay-plasma cell differentiation driven by pDCs could take
place. Recent studies demonstrating that myeloid DCs ette et al., 1998). However, at variance with pDCs, my-
eloid DCs, and most particularly the interstitial CD14drive T cell-independent and even CD40-independent
B cell differentiation and isotype switch, mediated by DCs, are able to induce the differentiation of naive B
pDCs Control Plasma Cells with IFN- and IL-6
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targeted IFN-R appear to mount normal antibody re-
sponses (van den Broek et al., 1995) suggesting alterna-
tive (redundant) pathways of plasma cell differentiation,
possibly through T cells and myeloid DCs which induce
B cell differentiation independently of type I IFN. Inter-
estingly, however, the double IFN-/ IFN-R/ mice
fail to produce LCMV-specific IgG2a and IgG2b (van
den Broek et al., 1995) while the single receptor
IFN--targeted mice produce normal levels (Muller et
al., 1994). This illustrates the limits of redundancy within
the immune system. The further elucidation of the role
of pDCs in the generation of virus-specific humoral im-
mune responses will require methods for specific pDC
depletion in vivo. The recently described lack of pDCs
in ICSBP/ mice (Schiavoni et al., 2002) may help us
address these questions.
The present findings are also relevant to systemic
Figure 6. Plasmacytoid Dendritic Cells Induce Plasma Cell Differen-
lupus erythematosus (SLE), an autoimmune diseasetiation through Interferon  and Interleukin 6
characterized by the break of tolerance to self-antigens.Upon virus encounter, pDCs promptly secrete IFN-. The cells
We had shown earlier that the interplay between DCdifferentiate into DCs presenting viral antigens to T cells, which
subsets may underlie immune alterations in SLE (Ben-promptly secrete IL-2 and turn on CD40 L that signals pDCs to
secrete IL-6 and activates B cells. Activated B cells differentiate nett et al., 2003; Blanco et al., 2001). There, the pDCs
into plasma blasts in response to the IFN-. The secretion of IL-6 release large amounts of IFN- (Bennett et al., 2003;
further induces the plasma blasts to become plasma cells. The Blanco et al., 2001), which induces monocytes to differ-
T cells also contribute importantly through their secretion of IL-2
entiate into mDCs. These DCs phagocytose cell nucleiand IL-10, the combination of all signals leading to the generation
that circulate in these patients’ blood, and their compo-of CD382 long-lived plasma cells.
nents are presented to autoreactive T cells and B cells,
leading to the increased production of autoantibodies
by plasma cells, the hallmark of SLE. The skewed B
cell differentiation in SLE could be explained by pDC-cells through the secretion of IL-12 and IL-6 (Dubois et
derived IFN- in at least two mechanisms, either throughal., 1998; Fayette et al., 1998). Our results here show
induction of BAFF/BLys on mDCs and/or direct effectthat B cells activated with pDCs preferentially secrete
on plasma blasts. The excess of IFN- in SLE may alsoIgG over IgM, suggesting that pDCs may specifically
explain the actual increase of plasma blast and plasmatarget memory B cells. Experiments are ongoing to es-
cells found in SLE blood (Arce et al., 2001). Accordingly,tablish whether the high IgG levels are due to the prefer-
two recent studies on murine SLE models showed ag-ential IgG switching of naive B cells or indeed the spe-
gravation of the disease and increased plasma cell num-cific activation of memory B cells. Our results show a
bers after induction of IFN- (Braun et al., 2003; Santi-cooperation of two pDC-derived cytokines, IFN- and
ago-Raber et al., 2003). Another unusual feature of SLEIL-6, at distinct stages of plasma cell differentiation. Yet,
blood B cells, i.e, coexpression of IgD and CD38, coulda combination of IL-6 and IFN- did not fully recapitulate
also be attributed to IFN- as we have previously shownthe effect of pDCs on Ig secretion. This suggests that
that IFN- can induce the expression of CD38 on B cellsother factors secreted by pDCs are involved in the pro-
in vitro (Galibert et al., 1996). In keeping with this, plasmacess. Among others, BAFF/BLyS and APRIL are known
cells generated with IFN- express very high levels ofto be involved in mDCs/B cell interactions (Balazs et al.,
CD38 similar to those found on circulating and tissular2002; Litinskiy et al., 2002; MacLennan and Vinuesa,
human plasma cells, further supporting the role of2002) and can be triggered on mDCs by IFN-. However,
IFN- in the generation of plasma cells in vivo.our genomic analysis of resting and virus-activated
In conclusion, pDCs appear critical for generation ofpDCs did not reveal increased transcription of BAFF/
plasma cells and anti-viral antibodies. Hence, the in vivoBlys and APRIL (B. Piqueras and A.K. Palucka, unpub-
targeting of pDCs, as proposed for mDCs (Hawiger etlished data ). Thus, distinct human DC subsets control B
al., 2001), may represent a novel approach to inducecell differentiation through different molecular pathways.
potent antiviral immune responses.Our study shows IFN- as an important molecule
in the generation of human antibody-secreting plasma
cells, thus providing a cellular mechanism for earlier
Experimental Procedures
studies that showed increased Ig secretion by IFN-
-treated B cells (Morikawa et al., 1987; Neubauer et Culture of PBMCs and Depletion of pDC
PBMCs were obtained from normal adult donors. pDCs were de-al., 1985; Peters et al., 1986). This function of type I
pleted using BDCA-4 microbeads (Miltenyi Biotec). BDCA-4 antigeninterferon in plasma blast differentiation herein de-
is specifically expressed on all human plasmacytoid dendritic cellsscribed adds to the list of IFN immunomodulatory effects
in blood. Isolated BDCA-4-positive cells have a typical phenotype,initially recognized 40 years ago (De Maeyer and De
morphology, and cytokine secretion profile of plasmacytoid den-
Maeyer-Guignard, 1980, 1988) and explains the recently dritic cells (Dzionek et al., 2000; Dzionek et al., 2002). 1  106 de-
observed adjuvant effect of type I IFN on humoral im- pleted or nondepleted PBMCs were then cultured with or without
104 influenza virus particles (Charles Rivers) in a 48-well plate withmune responses (Le Bon et al., 2001). Yet, mice with
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50 U/ml of IL-2 (R&D). At d15, supernatants were harvested and and Dr. Joseph Fay for their help in the collection of CD34 progenitor
cells, and Dr. Sophie Koutouzov for critical reading of this manu-used for indirect anti-influenza Ab and IgG ELISA.
script. J.B. is the holder of the Max and Gayle Clampitt Chair for
Immunology Research.
Isolation and Culture of B Cells and pDCs
B and CD4 T cells were purified from blood or tonsils with CD19 Received: April 22, 2003
and CD4 microbeads (Miltenyi Biotech), respectively. To remove Accepted: May 21, 2003
germinal center B cells, tonsils were first depleted of CD38hi cells Published: August 19, 2003
as previously described (Dubois et al., 1998). For Ig production, 4 
103 irradiated CD40L cells (9000 rads) were seeded with 104 B cells References
with or without 2.5 103 influenza virus particles, and with or without
pDC in a 96-well plate with 50 U/ml of IL-2. Monoclonal Abs against Arce, E., Jackson, D.G., Gill, M.A., Bennett, L.B., Banchereau, J.,
IL-6 and IL-6R and/or a rabbit anti-IFN-, rabbit anti-IFN-, and and Pascual, V. (2001). Increased frequency of pre-germinal center
mouse anti-IFN-R mAb (PBL biomedical) were added at the begin- B cells and plasma cell precursors in the blood of children with
ning of the culture. To induce the Ig secretion by a cytokine combina- systemic lupus erythematosus. J. Immunol. 167, 2361–2369.
tion, IL-6 (100 ng/ml; R&D) and IFN- (100 U/ml; Schering-Plough)
Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G.,
were added in the culture to IL-2 (50 U/ml). For Transwell (Costar)
Briere, F., Banchereau, J., and Liu, Y.J. (1995). Generation of memory
experiments, pDC (2  104) were cultured over overirradiated
B cells and plasma cells in vitro. Science 268, 720–722.
CD40L- or CD32-transfected L cells (5  104) in the lower compart-
Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad,ment (0.8 ml). B cells (1.5 104) were cultured over irradiated CD40L-
N., Dezutter-Dambuyant, C., Vicari, A., O’Garra, A., Biron, C., Briere,or CD32-transfected L cells (4  103) in the upper compartment (0.2
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